Pituitary tumors are both neurological and endocrine problems
The pituitary gland controls multiple hormonal systems, so a sellar mass cannot be assessed by MRI alone. Freiburg and Charité describe close cooperation between neurosurgery and endocrinology before and after surgery, while Heidelberg emphasizes laboratory hormone testing and, when needed, specialized endocrine function tests.
Define whether the adenoma is hormonally active
Pituitary adenomas can be hormonally active or inactive. Heidelberg notes that functioning adenomas can produce hormones such as prolactin, growth hormone or ACTH. The treatment plan therefore depends on the hormone pattern as well as tumor anatomy and symptoms.
- Current endocrine laboratory results and prior hormone trends
- Any dynamic endocrine function tests already performed
- Current hormone-replacement or hormone-suppressing medication
- Symptoms suggesting hormone excess or pituitary insufficiency
- Endocrinology reports and previous treatment response
MRI and visual assessment help define mass effect
Large pituitary tumors can compress the optic nerves or optic chiasm and cause visual-field or visual-acuity problems. Heidelberg and Charité describe ophthalmological assessment when visual pathways are threatened. Original sellar MRI images should be reviewed together with formal visual testing when vision is affected.
Prolactinoma is an important exception to an operation-first approach
Heidelberg states that prolactinomas should generally be treated medically first. Surgery can still become relevant when medication causes major side effects or does not provide adequate control. This is why the exact endocrine diagnosis should be established before comparing surgical centers or quotations.
Transsphenoidal surgery usually reaches the pituitary through the nose
Freiburg, Charité and Heidelberg all describe transsphenoidal surgery as the main operative route for many pituitary tumors. The procedure can use microscopic and/or endoscopic techniques, with neuronavigation available in specialist centers. Craniotomy is reserved for selected tumors whose size or extension makes a transnasal route insufficient.
Postoperative endocrine monitoring is part of treatment, not an optional extra
Pituitary surgery can change hormone function. Freiburg coordinates long-term follow-up with endocrinology, Charité describes pre- and postoperative endocrine diagnostics, and Heidelberg outlines postoperative hormone monitoring and later endocrine reassessment. International patients should plan this follow-up before travel rather than treating discharge as the end of care.
Residual or recurrent tumors may need another multidisciplinary decision
Charité describes cooperation with radiation oncology for recurrent or higher-grade pituitary tumors. The next step after incomplete resection or recurrence depends on pathology, residual anatomy, hormone activity, previous radiation and the risk of further surgery. A second opinion should therefore include prior operative and pathology records, not only the latest MRI.
Sudden deterioration is not a routine medical-travel scenario
Pituitary-region tumors can occasionally present with acute visual deterioration, including after tumor bleeding. Sudden severe headache, new marked visual loss, double vision, altered consciousness or other acute neurological deterioration requires urgent local medical assessment rather than waiting for an elective international consultation.
What to send for a German pituitary-tumor second opinion
A useful remote review combines original sellar imaging with endocrine and visual-function data.
- Current and previous pituitary / sellar MRI in DICOM format
- Radiology reports and evidence of growth over time
- Endocrine laboratory results and function tests
- Ophthalmology report and visual-field testing when available
- Current medications, including hormone replacement or dopamine agonists
- Operative report and pathology if previously treated
- Radiotherapy summary if previously irradiated
- A specific question: observe, continue medical therapy, operate, re-operate, irradiate or obtain another opinion
Official sources
Sources last checked 2026-09-01. Clinical pathways, eligibility and hospital procedures can change; confirm current requirements directly with the treating center.